Immune, Gene and Cell Therapy
Syllabus, Master's level, 3MG018
- Code
- 3MG018
- Education cycle
- Second cycle
- Main field(s) of study and in-depth level
- Medical Science A1N
- Grading system
- Fail (U), Pass (G)
- Finalised by
- The Educational Board of Medicine/Chair, 16 January 2013
- Responsible department
- Department of Immunology, Genetics and Pathology
General provisions
Requirements
At least 120 credits within medicine, biomedicine, biomedical laboratory science, pharmacy, biology or equivalent.
Entry requirements
120 credits within medicine, biomedicine, biomedical laboratory science, pharmacy, biology.
Learning outcomes
After the course the student should be able to:
Discuss different diseases that can benefit from immune-, gene-, or cell therapy
Discuss the principle of immunotherapy
Discuss the principle of gene therapy
Discuss the principle of cell therapy
Describe the role of the immune system in diseases such as cancer and autoimmunity
Discuss adoptive T cell therapy for cancer or infectious disease
Describe the process of Langerhans islet transplantation to patients with diabetes
Discuss how genes can be transferred to patients for therapy (e.g. describe a vector system, ex adenovirus)
Write an essay in the topic of immune-, gene-, or cell therapy with references included.
Content
The course gives an overview of new and established treatments based on immune, gene and cell therapy. The
course will discuss new opportunities as well as difficulties with these kind of therapies. Some areas that will be at
focus are: transplantation of endocrine cells, immunotherapy of cancer and stem cell transplantation.
Instruction
The course is a seminar series consisting of 10 meetings. The seminars will be held by scientists and/or medical
doctors in the field. The seminars will be held in English.
Assessment
Home examination: written essay
Other directives
Course leader: Peetra Magnusson phone 018-6119185